---
schema_version: "secwatch.filing_event.v1"
accession: "0001729149-23-000086"
form_type: "8-K"
ticker: "VMD"
cik: "0001729149"
company_name: "VIEMED HEALTHCARE, INC."
filed_at: "2023-06-01T23:59:59+00:00"
generated_at: "2026-06-14T09:33:03.444013+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Viemed completes $28M acquisition of Home Medical Products; guides Q2 rev $42.5M-$43.5M

## Summary
- Acquired HMP for ~$28M cash; funded by $15M cash on hand and $13M from existing credit facilities.
- HMP serves ~45,000 active patients with ~180 employees in Tennessee, Alabama, and Mississippi.
- Viemed expects Q2 2023 core net revenue of $42.5M-$43.5M, including one month of HMP revenue.
- Acquisition closed June 1, 2023; expands product, payor, and geographic diversity.

## SEC filing metadata
- accession: 0001729149-23-000086
- form_type: 8-K
- ticker: VMD
- cik: 0001729149
- company_name: VIEMED HEALTHCARE, INC.
- filed_at: 2023-06-01T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.01, 2.03, 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729149/000172914923000086/0001729149-23-000086-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729149/000172914923000086/vmd-20230601.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001729149-23-000086
- JSON: https://secwatch.observer/filing/0001729149-23-000086.json
- Plain text: https://secwatch.observer/filing/0001729149-23-000086.txt

## Key facts
- M&A Transactions
  VIEMED HEALTHCARE, INC. completed an acquisition involving Home Medical Products, Inc. for approximately $28 million in cash (closed 2023-06-01).
  - Action: acquisition
  - Counterparty: Home Medical Products, Inc.
  - Consideration: approximately $28 million in cash
  - Closing: 2023-06-01
  source text: HMP, Kevin Atkins and David Steele (collectively, the “Stockholders”). Viemed acquired from the Stockholders 100% of the equity ownership of HMP in exchange for approximately $28 million in cash, subject to customary post-closing net working capital and other adjustments. Approximately $15 million of the purchase consideration was funded by cash on hand, $8
  evidence_url: https://www.sec.gov/Archives/edgar/data/1729149/000172914923000086/0001729149-23-000086-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.